Asterias Biotherapeutics, Inc. - FORM S-1 - EX-23.1 - EXHIBIT 23.1 - April 3, 2013

Attached files

file filename
S-1 - ASTERIAS BIOTHERAPEUTICS, INC S-1 4-3-2013 - Asterias Biotherapeutics, Inc.forms1.htm
EX-3.2 - EXHIBIT 3.2 - Asterias Biotherapeutics, Inc.ex3_2.htm
EX-3.1 - EXHIBIT 3.1 - Asterias Biotherapeutics, Inc.ex3_1.htm
EX-4.2 - EXHIBIT 4.2 - Asterias Biotherapeutics, Inc.ex4_2.htm
EX-10.2 - EXHIBIT 10.2 - Asterias Biotherapeutics, Inc.ex10_2.htm
EX-10.4 - EXHIBIT 10.4 - Asterias Biotherapeutics, Inc.ex10_4.htm
EX-10.3 - EXHIBIT 10.3 - Asterias Biotherapeutics, Inc.ex10_3.htm
EX-10.5 - EXHIBIT 10.5 - Asterias Biotherapeutics, Inc.ex10_5.htm
EX-10.6 - EXHIBIT 10.6 - Asterias Biotherapeutics, Inc.ex10_6.htm
EXHIBIT 23.1
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 
We consent to the use in this Registration Statement on Form S-1 of our report dated April 2, 2013, relating to the financial statements of Asterias Biotherapeutics, Inc. and to the reference to our Firm under the caption “Experts” in the Prospectus.
 
/s/ Rothstein Kass

New York, New York
April 2, 2013
 
 

Asterias Biotherapeutics, Inc. Reports